201 related articles for article (PubMed ID: 20955354)
21. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results.
De Felice F; Musio D; Gravina GL; Marampon F; Tombolini V
Oncotarget; 2016 Nov; 7(48):80077-80082. PubMed ID: 27556300
[TBL] [Abstract][Full Text] [Related]
23. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
24. Surveillance following orchidectomy for stage I seminoma of the testis.
von der Maase H; Specht L; Jacobsen GK; Jakobsen A; Madsen EL; Pedersen M; Rørth M; Schultz H
Eur J Cancer; 1993; 29A(14):1931-4. PubMed ID: 8280484
[TBL] [Abstract][Full Text] [Related]
25. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
Aparicio J; Maroto P; García Del Muro X; Sánchez-Muñoz A; Gumà J; Margelí M; Sáenz A; Sagastibelza N; Castellano D; Arranz JA; Hervás D; Bastús R; Fernández-Aramburo A; Sastre J; Terrasa J; López-Brea M; Dorca J; Almenar D; Carles J; Hernández A; Germà JR
Ann Oncol; 2014 Nov; 25(11):2173-2178. PubMed ID: 25210015
[TBL] [Abstract][Full Text] [Related]
28. Management of stage I testicular seminoma over a period of 49 years.
Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant radiotherapy for Stage I seminoma: A Single-institutional experience.
Kanyilmaz G; Saricanbaz I; Bora H; Karahacioglu E; Erkal EY
J Cancer Res Ther; 2019 Mar; 15(Supplement):S87-S90. PubMed ID: 30900627
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
[TBL] [Abstract][Full Text] [Related]
31. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
32. Management of Stage II testicular seminoma over a period of 40 years.
Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based guidelines for following stage 1 seminoma.
Martin JM; Panzarella T; Zwahlen DR; Chung P; Warde P
Cancer; 2007 Jun; 109(11):2248-56. PubMed ID: 17437287
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
35. Surveillance in stage I testicular seminoma - risk of late relapse.
Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
[TBL] [Abstract][Full Text] [Related]
36. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
[TBL] [Abstract][Full Text] [Related]
39. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
[TBL] [Abstract][Full Text] [Related]
40. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]